AMGN

NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$326.31

-9.92 (-2.95%)

As of May 16, 1:00 AM ET ·

Financial Highlights (FY 2026)

Revenue

37.24B

Net Income

7.81B

Gross Margin

70.8%

Profit Margin

21.0%

Rev Growth

+11.8%

D/E Ratio

6.31

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	70.8%	70.8%	50.3%	50.3%
Operating Margin	25.4%	22.9%	1.8%	2.2%
Profit Margin	21.0%	19.9%	1.5%	1.7%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	37.24B	33.32B	561.58B	538.84B
Gross Profit	26.36B	23.59B	282.31B	270.88B
Operating Income	9.47B	7.63B	10.30B	11.85B
Net Income	7.81B	6.29B	8.50B	9.25B
Gross Margin	70.8%	70.8%	50.3%	50.3%
Operating Margin	25.4%	22.9%	1.8%	2.2%
Profit Margin	21.0%	19.9%	1.5%	1.7%
Rev Growth	+11.8%	+11.8%	+24.6%	+7.7%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	77.35B	77.35B	59.25B	55.06B
Total Equity	12.26B	12.26B	120.16B	131.87B
D/E Ratio	6.31	6.31	0.49	0.42

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	15.11B	12.84B	18.36B	16.26B
Free Cash Flow	—	—	5.30B	5.02B